Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Kristen Durkin

Nurse Practitioner, Adult Health Port Jefferson Station, NY Nurse Practitioner

NPI 1194107961 CMS profile 10940948

5316 Nesconset Hwy, Port Jefferson Station, NY 11776

Open in the dashboard

General payments

$254,689

1,011 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kristen Durkin of Port Jefferson Station, NY is reported in the CMS Open Payments database as having received $254,689 across 1,011 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $54,144 170
2024 General $53,796 198
2023 General $72,780 263
2022 General $60,474 251
2021 General $13,494 129

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kristen Durkin
  • Nurse Practitioner, Adult Health median
  • Middle half of Nurse Practitioner, Adult Health
  • National median

In program year 2025, general payments to Kristen Durkin were reported at $54,144. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.

Show as a table
Year Kristen Durkin Nurse Practitioner, Adult Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $13,494 $138 $43–$438 $132
2022 $60,474 $165 $54–$494 $149
2023 $72,780 $178 $61–$549 $160
2024 $53,796 $186 $62–$575 $164
2025 $54,144 $184 $59–$580 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Relievant Medsystems, Inc. $98,659 360 payments
  2. Boston Scientific Corporation $69,079 241 payments
  3. Nevro Corp. $42,996 127 payments
  4. Vertos Medical, Inc. $17,117 51 payments
  5. Globus Medical, Inc. $11,285 20 payments
  6. Nalu Medical, Inc. $3,367 18 payments
  7. MML US, Inc. $2,352 21 payments
  8. Stryker Corporation $1,789 10 payments
  9. Abbott Laboratories $1,586 9 payments
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $977 11 payments
  11. Other $5,481 143 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $127,307 217 payments
  2. Travel and Lodging $47,825 138 payments
  3. Consulting Fee $36,412 84 payments
  4. Food and Beverage $28,249 546 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $14,893 22 payments
  6. Education $2 4 payments
Products named General payments · program years 2021–2025
  1. Intracept Pain $100,675 366 payments
  2. Intracept Pain $47,779 176 payments
  3. Intracept Pain $47,779 176 payments
  4. Intracept Pain $47,779 176 payments
  5. Intracept Pain $41,945 148 payments
  6. Intracept Contains (1)Intracept RF Probe (2)Intracept Access Instruments_NMOD $27,025 86 payments
  7. Omnia $23,875 52 payments
  8. mild Device Kit $17,117 51 payments
  9. Senza Spinal Cord Stimulator $15,717 34 payments
  10. Senza Spinal Cord Stimulator $11,285 20 payments
  11. Other $44,218 376 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 29 drugs

Part D claims

1,411

Median for Nurse Practitioner: 389

Drug cost

$89,079

Median for Nurse Practitioner: $21,885

Branded share of claims

22.3%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycontin Oxycodone Hcl Brand 26 $18,931
Movantik Naloxegol Oxalate Brand 35 $15,363
Nucynta Tapentadol Hcl Brand 17 $15,224
Lidocaine Generic 25 $7,237
Xtampza Er Oxycodone Myristate Brand 13 $6,377
Pregabalin Generic 88 $3,893
Oxycodone Hcl Generic 163 $2,733
Diclofenac Sodium Generic 43 $2,435
Gabapentin Generic 186 $2,269
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 109 $2,194

The 10 drugs with the highest cost, of 29 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$28,214

Of which drugs: $5,670

Medicare patients

132

Average age 73

Services billed

3,327

86 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 45%
Diabetes 39%
Depression 32%
Osteoporosis 31%
Chronic kidney disease 24%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZTLido
$103 — —
ENTYVIO
$27 — —
QULIPTA
$9 — —
BOTOX
$9 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,011 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Adult Health in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record